The company reported a Phase 2 study of its injectable MariTide medicine showed an approximately 20% average weight loss over ...

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other ...

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...

Amgen's experimental drug MariTide helped overweight or obese patients shed up to 20% weight on average in a year-long ...

Amgen's experimental drug MariTide led to an average weight loss of up to 20% in a year-long mid-stage trial of people who ...

The pharmaceutical manufacturer Amgen announced on Tuesday that an experimental obesity drug helped patients lose up to 20 ...

MariTide, which like Eli Lilly’s Zepound is a dual agonist of the GLP-1 and GIP receptors, demonstrated an average weight ...

Shares in Amgen fell by double digits Tuesday on long-awaited results for the company’s monthly MariTide shot, which is ...

As officials put the change in draft rules for 2026, the incoming president's Medicare agency pick might support it.

A highly anticipated obesity-drug candidate from biotech Amgen helped patients shed a significant amount of weight in a ...

An Amgen obesity drug helped participants lose a substantial amount of weight, but questions about how competitive it could ...

Shares of Danish weight-loss drug maker Novo Nordisk rose 1.3% on Tuesday as U.S. President Joe Biden proposed expanding ...